1. Home
  2. NTRB vs CPIX Comparison

NTRB vs CPIX Comparison

Compare NTRB & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutriband Inc.

NTRB

Nutriband Inc.

HOLD

Current Price

$4.44

Market Cap

57.0M

Sector

Health Care

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$3.96

Market Cap

59.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRB
CPIX
Founded
2016
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.0M
59.5M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
NTRB
CPIX
Price
$4.44
$3.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
63.5K
216.1K
Earning Date
12-11-2025
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,278,321.00
$41,278,349.00
Revenue This Year
$30.17
N/A
Revenue Next Year
$3,394.36
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.69
12.21
52 Week Low
$4.17
$1.85
52 Week High
$11.78
$7.25

Technical Indicators

Market Signals
Indicator
NTRB
CPIX
Relative Strength Index (RSI) 49.36 45.85
Support Level $4.25 $3.84
Resistance Level $4.74 $4.92
Average True Range (ATR) 0.22 0.48
MACD 0.05 -0.14
Stochastic Oscillator 71.94 7.42

Price Performance

Historical Comparison
NTRB
CPIX

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: